97358 ⎘
Fusion polypeptide containing an RNA binding domain
GENE EDITING SYSTEMS AND METHODS FOR REDUCING IMMUNOGENICITY AND GRAFT VERSUS HOST RESPONSE
#2METHOD FOR DESIGNING RNA BINDING PROTEIN UTILIZING PPR MOTIF, AND USE THEREOF
#3RNA TICKERTAPE FOR RECORDING TRANSCRIPTIONAL HISTORIES OF CELLS
#4TRANS-SPLICING MOLECULES
#5TRAFFICKED RNAS FOR ASSESSMENT OF CELL-CELL CONNECTIVITY AND NEUROANATOMY
#6Sense-and-Response of Proteins, Peptides, and Small Molecules Using Ligand-Induced Dimerization Activating RNA Editing (LIDAR)
#7SYSTEMS AND METHODS FOR PROMOTING TRANS-SPLICING
#8RECOMBINANT ENHANCED ANTIVIRAL RESTRICTORS
#9SARS-CoV-2 Vaccine Constructs
#10MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF
#11ENZYME, COMPLEX, RECOMBINANT VECTOR, THERAPEUTIC AGENT FOR GENETIC DISORDER, AND POLYNUCLEOTIDE
#12COMPOSITIONS AND METHODS FOR PROMOTING HOMOLOGY DIRECTED REPAIR
#13Methods and compositions for endogenous exon splicing using dCas13-RBM25 fusions
#14METHODS AND COMPOSITIONS RELATING TO A GROUP II INTRON REVERSE TRANSCRIPTASE
#15PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF GENOME-EDITING MOLECULES
#16CLASS 2 TYPE V CRISPR-CAS PRIME EDITING
#17MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF
#18MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF
#19Population-Hastened Assembly Genetic Engineering
#20Materials & Methods for Treatment of Macular Degeneration
#21FUSOGENIC PEPTIDE COMPOSITIONS AND METHODS OF CARGO DELIVERY
#22NUCLEIC ACID-GUIDED NICKASE FUSION PROTEINS
#23TRIGGER NUCLEIC ACIDS AND RNA-BINDING PROTEINS FOR UPREGULATING GENE EXPRESSION
#24HYBRID REVERSE TRANSCRIPTASES
#25ENGINEERED MCP AND PCP PROTEINS AND SYSTEMS AND METHODS THEREOF
#26NUCLEIC ACID-GUIDED NUCLEASES
#27FUSION PROTEINS FOR PURIFYING NUCLEIC ACIDS
#28SYNTHETIC REVERSE TRANSCRIPTASES AND USES THEREOF
#29Gene Targeting
#30COMPOSITION FOR MODIFYING NUCLEIC ACID SEQUENCE, AND METHOD FOR MODIFYING TARGET SITE OF NUCLEIC ACID SEQUENCE
#31TREATMENT OF FRAGILE X SYNDROME
#32ENGINEERED CAS13 FOR ULTRASENSITIVE NUCLEIC ACID DETECTION
#33METHODS AND COMPOSITIONS FOR PRIME EDITING RNA
#34METHODS AND SYSTEMS FOR MODIFYING THE CRUMBS HOMOLOGUE-1 (CRB1) GENE
#35TARGETED EXTRACELLULAR VESICLES COMPRISING MEMBRANE PROTEINS WITH ENGINEERED GLYCOSYLATION SITES
#36DELIVERY OF CAS9 VIA ARRDC1-MEDIATED MICROVESICLES (ARMMS)
#37TRANS-SPLICING MOLECULES
#38SYSTEMS, METHODS, AND COMPOSITIONS FOR RNA-GUIDED RNA-TARGETING CRISPR EFFECTORS
#39TAQ-NEQSSB POLYMERASE, THE METHOD OF ITS OBTAINING, RECOMBINANT PLASMID, PRIMERS, AND APPLICATION OF THE POLYMERASE
#40METHODS AND COMPOSITIONS FOR TREATMENT OF VIRAL INFECTION
#41COMPOSITIONS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS TO ACCEPTOR CELLS
#42MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF
#43TARGETED DNA DEMETHYLATION AND METHYLATION
#44SYNTHETIC IMMUNOMODULATION WITH A CRISPR SUPER-REPRESSOR IN VIVO
#45RECOMBINANT EXPRESSION VECTOR FOR PRODUCTION OF ENCAPSULIN-BASED VACCINE AND METHOD FOR MANUFACTURING THE SAME
#46GENE EDITING COMPONENTS, SYSTEMS, AND METHODS OF USE
#47METHOD FOR DESIGNING RNA BINDING PROTEIN UTILIZING PPR MOTIF, AND USE THEREOF
#48INHIBITION OF UNINTENDED MUTATIONS IN GENE EDITING
#49Micro-Vesicles Comprising Cargo Prodrug RNA and Methods of Using the Same
#50COMPOSITIONS AND METHODS FOR EPIGENOME EDITING
#51IN-CELL CONTINUOUS TARGET-GENE EVOLUTION, SCREENING AND SELECTION
#52METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION
#53Inhibition of unintended mutations in gene editing
#54CELL-TO-CELL DELIVERY OF RNA CIRCUITS
#55EXPORTED RNA REPORTERS FOR LIVE-CELL MEASUREMENT
#56METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION
#57Compositions and methods for identifying RNA binding polypeptide targets
#58LIBRARY OF BARCODED EXTRACELLULAR VESICLES
#59PROTEIN TAG TO INDUCE LIGAND DEPENDENT DEGRADATION OF PROTEIN/PROTEIN-FUSIONS
#60Nucleic acid-guided nucleases
#61BASE EDITORS WITH DIVERSIFIED TARGETING SCOPE
#62NOVEL GENOME EDITING TOOL
#63RNA-REGULATED FUSION PROTEINS AND METHODS OF THEIR USE
#64Highly Efficient DNA Base Editors Mediated By RNA-Aptamer Recruitment For Targeted Genome Modification And Uses Thereof
#65EFFICIENT METHOD FOR PREPARING PPR PROTEIN AND USE OF THE SAME
#66Targeted RNA cleavage with CRISPR-Cas
#67EXOSOME COMPRISING STABILIZED RNA THERAPEUTICS
#68COMPOSITIONS AND METHODS FOR HOMOLOGY DIRECTED REPAIR
#69CHIMERIC PROTEINS FOR TARGETING dsRNA
#70Genome editing system
#71Targeted Nuclear RNA Cleavage and Polyadenylation with CRISPR-Cas
#72Systems, methods, and compositions for RNA-guided RNA-targeting CRISPR effectors
#73Compositions and methods for promoting homology directed repair
#74Inhibition of unintended mutations in gene editing
#75SYSTEMS AND METHODS FOR MODULATING RNA
#76METHODS OF MODULATING RNA
#77Peptide probe for recognition of G-quadruplex and use thereof in detection of G-quadruplex in cell
#78Synthetic reverse transcriptases and uses thereof
#79Synthetic immunomodulation with a CRISPR super-repressor in vivo
#80Gene Targeting
#81Argonaute protein mutant and use thereof
#82DELIVERY OF NEGATIVELY CHARGED PROTEINS USING CATIONIC LIPIDS
#83RETROVIRAL PARTICLE COMPRISING AT LEAST TWO ENCAPSIDATED NONVIRAL RNAS
#84Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs)
#85Synthetic RNA binding polypeptides
#86Method for designing RNA-binding protein utilizing PPR motif, and use thereof
#87Gene Targeting
#88Modified cascade ribonucleoproteins and uses thereof
#89Trans-splicing molecules
#90RNA-TARGETING FUSION PROTEIN COMPOSITIONS AND METHODS FOR USE
#91Hybrid reverse transcriptases
#92A RECOMBINANT PROTEIN COMPRISING A DOUBLE STRANDED RNA BINDING DOMAIN
#93SELF-DIVERSIFYING SYSTEMS AND METHODS OF USE THEREOF
#94Method for NK cell transduction
#95Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites
#96CAS9-nucleic acid complexes and uses related thereto
#97GENOME ENGINEERING WITH CRISPR-CAS SYSTEMS IN EUKARYOTES
#98TREATMENT OF FRAGILE X SYNDROME
#99Modified cascade ribonucleoproteins and uses thereof
#100DELIVERY SYSTEM FOR FUNCTIONAL NUCLEASES
#101TARGETED AND MODULAR EXOSOME LOADING SYSTEM
#102Method for designing RNA-binding protein utilizing PPR motif, and use thereof
#103CHIMERIC RECEPTORS
#104Chimeric enzymes and their applications
#105RNA-targeting fusion protein compositions and methods for use
#106Particle for the encapsidation of a genome engineering system
#107Targeted DNA demethylation and methylation
#108Population-Hastened Assembly Genetic Engineering
#109Modified cascade ribonucleoproteins and uses thereof
#110PLASMA CELL CYTOKINE VEHICLE CONTAINING FUSION PROTEINS FOR TARGETED INTRODUCTION OF SIRNA INTO CELLS AND TISSUES
#111Mapping a Functional Cancer Genome Atlas of Tumor Suppressors Using AAV-CRISPR Mediated Direct In Vivo Screening
#112Compositions and methods for identifying RNA binding polypeptide targets
#113Synthetic reverse transcriptases and uses thereof
#114Nucleic acid-guided nucleases
#115MALARIA VACCINE
#116Method for designing RNA binding protein utilizing PPR motif, and use thereof
#117Recombinant protein-based method for the delivery of silencer RNA to target the brain
#118METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION
#119Proximity-dependent biotinylation and uses thereof
#120Delivery of cargo proteins via ARRDC1-mediated microvesicles (ARMMs)
#121TARGETED ENHANCED DNA DEMETHYLATION
#122Viral particle for the transfer of RNAs, especially into cells involved in immune response
#123COMPOSITIONS AND METHODS FOR CELL TARGETED HPV TREATMENT
#124Chimeric proteins for targeting dsRNA
#125Synthetic MBNL proteins for treatment of repeat expansion disease
#126Methods and compositions for synthetic RNA endonucleases
#127COMPOSITION FOR SOLUBILIZING TARGET PROTEIN AND USE THEREOF
#128ASSAY FOR THE REMOVAL OF METHYL-CYTOSINE RESIDUES FROM DNA
#129Synthetic compound for improving efficiency of transfection
#130Methods and compositions for modulating gene expression
#131Chimeric proteins for targeting dsRNA
#132Methods of Inducibly Targeting Chromatin Effectors and Compositions for Use in the Same
#133Plasma cell cytokine vehicle containing fusion proteins for targeted introduction of siRNA into cells and tissues
#134COMPOSITIONS AND METHODS FOR PROMOTING HOMOLOGY DIRECTED REPAIR
#135Method for designing RNA binding protein utilizing PPR motif, and use thereof
#136Delivery of negatively charged proteins using cationic lipids
#137Dominant positive hnRNP-E1 polypeptide compositions and methods
#138Methods and compositions for modulating gene expression
#139Site-specific DNA base editing using modified APOBEC enzymes
#140Retroviral particle comprising at least two encapsidated nonviral RNAs
#141Modified cascade ribonucleoproteins and uses thereof
#142Delivery of cargo proteins via ARRDC1-mediated microvesicles (ARMMs)
#143RNA-guided gene editing system and uses thereof
#144CHIMERIC VSV-G PROTEINS AS NUCLEIC ACID TRANSFER VEHICLES
#145Engineered exosomes for the delivery of bioactive cargo using transmembrane tetraspanins
#146Site-directed CRISPR/recombinase compositions and methods of integrating transgenes
#147Programmable polypeptide and nucleic acid nanoparticles
#148Peptides for the specific binding of RNA targets
#149Method for designing RNA binding protein utilizing PPR motif, and use thereof
#150PLANT PLASTID TRANSFORMATION METHOD
#151Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites
#152Polypeptide tagging fusions and methods
#153Compositions and methods for delivering inhibitory oligonucleotides
#154Subunit vaccine platform based on multimeric ribonucleoproteins comprising nucleoproteins of a non-segmented negative-strand RNA virus as carriers of heterologous polypeptides
#155Universal protein tag for double stranded nucleic acid delivery
#156Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs)
#157Delivery system for functional nucleases
#158Modified cascade ribonucleoproteins and uses thereof
#159Compositions, methods and kits for real-time nucleic acid analysis in live cells
#160Treating human immunodeficiency virus infections
#161Chimeric VSV-G proteins as nucleic acid transfer vehicles
#162DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IMMUNE CELL RECEPTORS AND AUTOANTIGENS
#163Delivery of negatively charged proteins using cationic lipids
#164Targeted and modular exosome loading system
#165Delivery system for functional nucleases
#166Use of cationic lipids to deliver CAS9
#167Cell permeable fusion protein for facilitating reprogramming induction and use thereof
#168Compositions and methods for delivering inhibitory oligonucleotides
#169Malaria vaccine
#170Method for designing RNA binding protein utilizing PPR motif, and use thereof
#171Compositions of a peptide targeting system for treating cancer
#172Nucleic acid construct, nucleic acid-protein complex, and use thereof
#173Peptides for the specific binding of RNA targets
#174Compositions and Methods for the Delivery of Biologically Active RNAs
#175Recombinant protein for intracellular delivery of siRNA and composition comprising the same
#176Methods and compositions for synthetic RNA endonucleases
#177RNA- AND DNA-COPYING ENZYMES
#178POSITIVE CYTOMODULINES TO IMPROVE BIOREACTOR PRODUCTIVITY
#179METHOD OF DELIVERING RNA INTERFERENCE AND USES THEREOF
#180FUSION POLYPEPTIDES AND USES THEREOF
#181Compositions of a peptide targeting system for treating cancer
#182Enhancing drought tolerance and bacterial resistance of crop species by functional interference of 14-3-3
#183Chimeric Virus Vaccines
#184TARGETING NUCLEIC ACIDS IN MITOCHONDRIA
#185Transducible delivery of nucleic acids using modified dsRNA binding domains
#186MODIFIED PLANT VIRUS PARTICLES AND USES THEREFOR
#187Plant plastid transformation method
#188Targeted delivery of nucleic acids
#189Antigenic compositions and use of same in the targeted delivery of nucleic acids
#190Compositions and methods for delivering inhibitory oligonucleotides
#191Methods of detecting transcription
#192Transducible delivery of siRNA by dsRNA binding domain fusions to PTD/CPPS
#193Method of delivering RNA interference and uses thereof
#194Peptide protein translation inhibitor and the use thereof for protein translation control
#195Method for improving solubility and folding efficiency of target proteins using RNA as molecular chaperone